{
    "id": "7ff814c8-c6d1-4b4d-98c2-6bd5a277fe75",
    "indications": {
        "text": "scopolamine transdermal system indicated adults prevention : \u2022nausea vomiting associated motion sickness . \u2022post-operative nausea vomiting ( ponv ) associated recovery anesthesia and/or opiate analgesia surgery .",
        "doid_entities": [
            {
                "text": "motion sickness (DOID:2951)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2951"
            },
            {
                "text": "analgesia (DOID:0060145)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060145"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "application removal ( 2.1 ) : \u2022 scopolamine transdermal system delivers 1 mg scopolamine 3 days . \u2022 wear one transdermal system time . \u2022 cut transdermal system . \u2022 wash hands thoroughly soap water application . \u2022 avoid touching applying pressure transdermal system applied . \u2022 upon removal , fold used transdermal system half sticky side together , discard prevent accidental contact ingestion , wash hands application site soap water . recommended : \u2022 motion sickness : apply one transdermal system hairless area behind one ear least 4 hours antiemetic effect required 3 days . therapy 3 days required , remove first transdermal system apply new transdermal system behind ear . ( 2.2 ) \u2022 ponv : surgeries cesarean section , apply one transdermal system behind ear evening surgery remove 24 hours following surgery . ( 2.2 )",
        "doid_entities": [
            {
                "text": "motion sickness (DOID:2951)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2951"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "scopolamine transdermal system , 1 mg/3 days available following : carton 4 transdermal systems , packaged individual square pouches . ndc 0378-6470-99 carton 10 transdermal systems , packaged individual square pouches . ndc 0378-6470-97 carton 24 transdermal systems , packaged individual square pouches . ndc 0378-6470-44 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp controlled room temperature . ] store pouch ( es ) upright position . bend roll pouch ( es ) . wash hands thoroughly soap water immediately handling transdermal system . avoid touching system treatment . upon removal , fold used transdermal system half sticky side together , discard household trash manner prevents accidental contact ingestion children , pets others . wash hands application site soap water transdermal system removal [ ( 2.1 ) , ( 5.7 ) ] .",
    "adverseReactions": "scopolamine transdermal system contraindicated patients : \u2022angle closure glaucoma [ ( 5.1 ) ] . \u2022hypersensitivity scopolamine belladonna alkaloids ingredient component formulation delivery system . included rash generalized erythema [ ( 6.2 ) , description ( 11 ) ] .",
    "ingredients": [
        {
            "name": "SCOPOLAMINE",
            "code": "DL48G20X8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16794"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S)",
            "code": "5VBE2X0WG0"
        },
        {
            "name": "D&C BLACK NO. 2",
            "code": "4XYU5U00C4"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "DIMETHICONE",
            "code": "92RU3N3Y1O",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11074"
        },
        {
            "name": "POLYTETRAFLUOROETHYLENE",
            "code": "E1NC1JVS3O"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_78913"
        },
        {
            "name": "DOCUSATE SODIUM",
            "code": "F05Q2T2JA0",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11089"
        },
        {
            "name": "TROLAMINE",
            "code": "9O3K93S3TK",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13747"
        }
    ],
    "organization": "Mylan Pharmaceuticals Inc.",
    "name": "Scopolamine",
    "effectiveTime": "20250513",
    "indications_original": "Scopolamine transdermal system is indicated in adults for the prevention of:\n                  \n                     \n                        \u2022nausea and vomiting associated with motion sickness.\n                     \n                        \u2022post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery.",
    "contraindications_original": "Application and Removal ( 2.1 ): \u2022 Each scopolamine transdermal system delivers 1 mg of scopolamine over 3 days. \u2022 Only wear one transdermal system at a time. \u2022 Do not cut the transdermal system. \u2022 Wash hands thoroughly with soap and water after application. \u2022 Avoid touching or applying pressure to the transdermal system once applied. \u2022 Upon removal, fold used transdermal system in half with sticky side together, discard to prevent accidental contact or ingestion, and wash your hands and application site with soap and water. Recommended Dosage : \u2022 Motion Sickness :\u00a0Apply one transdermal system to the hairless area behind one ear at least 4 hours before antiemetic effect is required for use up to 3 days. If therapy for more than 3 days is required, remove the first transdermal system and apply a new transdermal system behind the other ear. ( 2.2 ) \u2022 PONV :\u00a0For surgeries other than cesarean section, apply one transdermal system behind the ear the evening before surgery and remove 24 hours following surgery. ( 2.2 )",
    "warningsAndPrecautions_original": "Scopolamine Transdermal System, 1 mg/3 days is available as the following: \n                  Carton of 4 transdermal systems, packaged into individual square pouches. NDC 0378-6470-99\n                  Carton of 10 transdermal systems, packaged into individual square pouches. NDC 0378-6470-97\n                  Carton of 24 transdermal systems, packaged into individual square pouches. NDC 0378-6470-44\n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP Controlled Room Temperature.]\n                  \n                  Store pouch(es) in an upright position. \n                  Do not bend or roll pouch(es).\n                  Wash hands thoroughly with soap and water immediately after handling the transdermal system. Avoid touching the system during treatment. Upon removal, fold the used transdermal system in half with the sticky side together, and discard in household trash in a manner that prevents accidental contact or ingestion by children, pets or others. Wash your hands and application site with soap and water after transdermal system removal [see Dosage and Administration (2.1), Warnings and Precautions (5.7)].",
    "adverseReactions_original": "Scopolamine transdermal system is contraindicated in patients with:\n                  \n                     \n                        \u2022angle closure glaucoma [see Warnings and Precautions (5.1)].\n                     \n                        \u2022hypersensitivity to scopolamine or other belladonna alkaloids or to any ingredient or component in the formulation or delivery system. Reactions have included rash generalized and erythema [see Adverse Reactions (6.2), Description (11)].",
    "drug": [
        {
            "name": "Scopolamine",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16794"
        }
    ]
}